CLINICAL SIGNIFICANCE OF BAFF/BLyS AND APRIL IN SYSTEMIC LUPUS ERYTHEMATOSUS AND RHEUMATOID ARTHRITIS

CLINICAL SIGNIFICANCE OF BAFF/BLyS AND APRIL IN SYSTEMIC LUPUS ERYTHEMATOSUS AND RHEUMATOID ARTHRITIS

The present work is devoted to mechanisms of action of cytokines BAFF/BLyS and APRIL in immune inflammatory rheumatic diseases; correlation between the level of this cytokines and activity of rheumatic arthritis and systemic lupus erythematosus (SLE); impact of the biologic agents on the level of BA...

Full description

Bibliographic Details
Main Authors:	E. V. Suponitskya, E. N. Aleksandrova, E. L. Nasonov
Format:	Article
Language:	Russian
Published:	IMA-PRESS LLC 2014-10-01
Series:	Научно-практическая ревматология
Subjects:	baff/blys april rheumatoid arthritis systemic lupus erythematosus genetically engineered biologic drugs
Online Access:	https://rsp.mediar-press.net/rsp/article/view/1990

Similar Items

CLINICAL VALUE OF BAFF AND APRIL CONCENTRATIONS IN SYSTEMIC LUPUS ERYTHEMATOSUS
by: T. A. Panafidina, et al.
Published: (2016-07-01)

Expression of BAFF, APRIL, and cognate receptor genes in lupus nephritis and potential use as urinary biomarkers
by: David Aguirre-Valencia, et al.
Published: (2020-01-01)

Association Between Changes in BLyS Levels and the Composition of B and T Cell Compartments in Patients With Refractory Systemic Lupus Erythematosus Treated With Belimumab
by: Francesca Regola, et al.
Published: (2019-04-01)

B cells targeting therapy in the management of systemic lupus erythematosus
by: Wen Shi Lee, et al.
Published: (2020-01-01)

Spotlight on blisibimod and its potential in the treatment of systemic lupus erythematosus: evidence to date
by: Lenert A, et al.
Published: (2017-03-01)

The interplay of IL-21 and BAFF in the formation and maintenance of human B cell memory
by: Jodi eKarnell, et al.
Published: (2012-01-01)

Inhibition of Membrane-Bound BAFF by the Anti-BAFF Antibody Belimumab
by: Christine Kowalczyk-Quintas, et al.
Published: (2018-11-01)

BAFF, APRIL, and their receptors: physiological role and involvement in the pathogenesis of chronic lymphocytic leukemia
by: Katarzyna Schab, et al.
Published: (2018-09-01)

Prospects for anti-BLyS treatment of systemic lupus erythematosus
by: S. K. Solovyov, et al.
Published: (2019-06-01)

Bioinformatic Prediction of miRNAs Targeting APRIL and BAFF Genes in Chronic Lymphocytic Leukemia
by: Mahdieh Mondanizadeh, et al.
Published: (2019-11-01)

Expression of BAFF and BR3 in patients with systemic lupus erythematosus
by: J.H. Duan, et al.
Published: (2016-03-01)

BlyS is up-regulated by hypoxia and promotes migration of human breast cancer cells
by: Zhu Jing, et al.
Published: (2012-03-01)

B lymphocyte stimulator modulates number and function of endothelial progenitor cells in systemic lupus erythematosus
by: Francesca Romana Spinelli, et al.
Published: (2019-11-01)

Tuberculosis increases the survival of B-cells through the BAFF system molecules in HIV patients
by: Asante, Phoebe Ohemah
Published: (2021)

Profiling of B-Cell Factors and Their Decoy Receptors in Rheumatoid Arthritis: Association With Clinical Features and Treatment Outcomes
by: Javier Rodríguez-Carrio, et al.
Published: (2018-10-01)

ROLE DES MEMBRES DE LA FAMILLE BAFF/APRIL DANS LE MYELOME MULTIPLE : IMPLICATIONS PHYSIOPATHOLOGIQUES ET INTERET THERAPEUTIQUE
by: Moreaux, Jérome
Published: (2006)

Susceptibility of BAFF-var allele carriers to severe SLE with occurrence of lupus nephritis
by: Justa Friebus-Kardash, et al.
Published: (2019-11-01)

Lupus erythematosus cells in vivo (pleural fluid): An unusual presentation of systemic lupus erythematosus
by: Majed Momin, et al.
Published: (2016-01-01)

BCMA (TNFRSF17) Induces APRIL and BAFF Mediated Breast Cancer Cell Stemness
by: Vasiliki Pelekanou, et al.
Published: (2018-08-01)

Long-lived plasma cells in autoimmunity: lessons from B-cell depleting therapies.
by: Matthieu eMahévas, et al.
Published: (2013-12-01)

Expression of B-cell activating factor, a proliferating inducing ligand and its receptors in primary central nervous system lymphoma
by: Tobias Birnbaum, et al.
Published: (2013-03-01)

Pregnancy outcomes in patients with rheumatoid arthritis and systemic lupus erythematosus. Part I. Maternal outcomes
by: N. M. Kosheleva, et al.
Published: (2019-05-01)

Pregnancy outcomes in patients with rheumatoid arthritis and systemic lupus erythematosus. Part II. Neonatal outcomes
by: E. V. Matyanova, et al.
Published: (2019-07-01)

Neurological complications in systemic lupus erythematosus and rheumatoid arthritis
by: Agnieszka Damiza-Detmer, et al.
Published: (2018-12-01)

A Novel Pool of Microparticle Cholesterol Is Elevated in Rheumatoid Arthritis but Not in Systemic Lupus Erythematosus Patients
by: Shuaishuai Hu, et al.
Published: (2020-12-01)

Extracellular Vesicles in Rheumatoid Arthritis and Systemic Lupus Erythematosus: Functions and Applications
by: Bo Zhang, et al.
Published: (2021-01-01)

Medication adherence in patients in treatment for rheumatoid arthritis and systemic lupus erythematosus in a university hospital in Brazil
by: Prudente LR, et al.
Published: (2016-05-01)

Roles for BLyS family members in meeting the distinct homeostatic demands of innate and adaptive B cells
by: Michael P. Cancro, et al.
Published: (2013-02-01)

The role of alpha-2-macroglobulin in pathogenesis of rheumatoid arthritis and system lupus erythematosus
by: V. N. Zorina, et al.
Published: (2010-10-01)

Endothelial activation and injury by microparticles in patients with systemic lupus erythematosus and rheumatoid arthritis
by: Laura Atehortúa, et al.
Published: (2019-01-01)

Physical activity and sedentary behavior in patients with systemic lupus erythematosus and rheumatoid arthritis
by: Legge A, et al.
Published: (2017-11-01)

Hydroxychloroquine decreases Th17-related cytokines in systemic lupus erythematosus and rheumatoid arthritis patients
by: Juliana Cruz da Silva, et al.
Published: (2013-06-01)

Fatigue in Systemic Lupus Erythematosus and Rheumatoid Arthritis: A Comparison of Mechanisms, Measures and Management
by: Mrinalini Dey, et al.
Published: (2021-08-01)

Cutaneous lupus erythematosus: An update
by: Carina M Grönhagen, et al.
Published: (2014-01-01)

Diet in Rheumatoid Arthritis versus Systemic Lupus Erythematosus: Any Differences?
by: Alessia Alunno, et al.
Published: (2021-02-01)

Lupus serum IgG induces microglia activation through Fc fragment dependent way and modulated by B-cell activating factor
by: Chunshu Yang, et al.
Published: (2019-12-01)

Simultaneous Occurrence of Systemic Lupus Erythematosus, Rheumatoid Arthritis, Hashimoto’s Thyroiditis and Membranous Glomerulonephritis
by: Lilia Baili, et al.
Published: (2014-11-01)

The TNFSF Members APRIL and BAFF and Their Receptors TACI, BCMA, and BAFFR in Oncology, With a Special Focus in Breast Cancer
by: Marilena Kampa, et al.
Published: (2020-06-01)

GLUCOCORTICOIDS IN THE THERAPY OF SYSTEMIC LUPUS ERYTHEMATOSUS
by: T. M. Reshetnyak, et al.
Published: (2014-07-01)

GLUCOCORTICOIDS IN THE THERAPY OF SYSTEMIC LUPUS ERYTHEMATOSUS
by: T. M. Reshetnyak, et al.
Published: (2014-07-01)